Facebook’s SLAUGHTER and 4 Stocks Hitting 52-Week Lows

Aecom Technology Cor (NYSE:ACM) has been selected as a design contractor on the North Road upgrade, a part of the Qatar Expressway project in Qatar that involves an investment of $20 billion to build 342 miles of expressways and service roads for improving the overall roads network and the prospects of Qatar’s economy.

Astrazeneca Plc (NYSE:AZN): Shares fell to new 52-week after Ardea Biosciences (NASDAQ:RDEA) announced, in connection with Ardea’s pending merger with a 100 percent subsidiary of Astra Zeneca, that the waiting period under the Hart-Scott Rodino Antitrust Improvements Act of 1976, as amended, or HSR, had duly expired, and that the merger could be expected to complete in the second quarter of CY 2012.

Don’t Miss: MOBILE GENIUS? Facebook’s New Monetization Strategy REVEALED.

Facebook Inc (NASDAQ:FB): Shares closed lower on a survey by Reuters that said almost 34 percent of those polled were spending less time on Facebook, while merely 20 percent said they spent more time on the site, raising concerns on future user growth. Fresh concerns arose on the efficacy of Facebook’s advertising after 80 percent of those polled said they were never driven to buy something by a Facebook ad.

France Telecom S.A. (NYSE:FTE): Shares of the company slid 9.07 percent, or $1.17 to $11.73 following remarks at the annual meeting by CEO Stephanie Richard that cited the large number of telecom players in the European market and the inevitable consolidation via mergers that would follow.

Polypore Internation (NYSE:PPO): Shares of the company reacted positively to the news that sales in California of GM’s (NYSE:GM) Chevrolet Volt have been soaring recently – Polypore makes the lithium separator that is used in the Volt’s batteries.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

Don’t Miss: Does Nokia Have the Answer to Remaining Relevant?